A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Drotebanol
Sulfaphenazole
The metabolism of Enasidenib can be decreased when combined with Sulfaphenazole.
Drotebanol
Dosulepin
The metabolism of Dosulepin can be decreased when combined with Enasidenib.
Drotebanol
Cyproterone acetate
The metabolism of Enasidenib can be increased when combined with Cyproterone acetate.
Drotebanol
(S)-Warfarin
The metabolism of (S)-Warfarin can be increased when combined with Enasidenib.
Drotebanol
S,R-Warfarin alcohol
The metabolism of S,R-Warfarin alcohol can be increased when combined with Enasidenib.
Drotebanol
R,S-Warfarin alcohol
The metabolism of R,S-Warfarin alcohol can be increased when combined with Enasidenib.
Drotebanol
(R)-warfarin
The metabolism of (R)-warfarin can be increased when combined with Enasidenib.
Drotebanol
Perampanel
The metabolism of Perampanel can be increased when combined with Enasidenib.
Drotebanol
Metreleptin
The metabolism of Enasidenib can be increased when combined with Metreleptin.
Drotebanol
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Enasidenib.
Drotebanol
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Enasidenib.
Drotebanol
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Enasidenib.
Drotebanol
Deferasirox
The serum concentration of Enasidenib can be increased when it is combined with Deferasirox.
Drotebanol
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be increased when combined with Enasidenib.
Drotebanol
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Enasidenib.
Drotebanol
Armodafinil
The metabolism of Enasidenib can be increased when combined with Armodafinil.
Drotebanol
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Enasidenib.
Drotebanol
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Enasidenib.
Etryptamine
Somapacitan
The serum concentration of the active metabolites of Fluticasone can be decreased when Fluticasone is used in combination with Somapacitan.
Etryptamine
Satralizumab
The serum concentration of Fluticasone can be decreased when it is combined with Satralizumab.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3